22 Oct

Jury Awards $4.5 Million to Victim in Wright Profemur Lawsuit

October 22, 2015--  A Los Angeles jury laid down the law in determining that Wright was defective in manufacturing the Profemur hip implant. The plaintiff was awarded $4.5 million after...

21 Oct

Congressman’s Essure Bill Puts Pressure on FDA

October 19th, 2015-- Pennsylvania Congressman Mike Fitzpatrick is joining in the fight to get Essure recalled from the market. Fitzpatrick has officially drafted legislation, entitled the E-Free Act, which he will...

20 Oct

J&J Slapped With $5.6 Million Verdict Over Risperdal Death

October 20, 2015- A California jury on Friday hit Johnson & Johnson unit, Janssen Pharmaceuticals, with a $5.6 million verdict for the wrongful death of a man during a clinical study...

19 Oct

FDA Grants Fast Approval of Pradaxa, Xarelto Antidote

October 19, 2015  San Diego, CA -- With the lack of an antidote to reverse the effects of new-age anticoagulants like Pradaxa or Xarelto, doctors have been hesitant to prescribe...

16 Oct

Is Xarelto Potentially Linked to Increased Risk of Liver Injury?

Health Canada recently completed a safety review of Xarelto, an anti-coagulant medication manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. According to a Summary Safety Review, which was...

15 Oct

Ohio Parents Allege Zofran Caused Infant’s Death

October 15, San Diego, CA- Back in 1999, the FDA approved Zofran, a drug manufactured by GlaxoSmithKine, for use in cancer patients requiring chemotherapy or radiation therapy. While Zofran is used...

15 Oct

Xarelto TV Commercial

October 15, 2015 Xarelto TV Commercial as seen on TV.  National Injury Attorneys, LLC helps people who have been hurt from taking Xarelto. If you or a loved one have...

14 Oct

New Research Reveals Essure Has Higher Need for Reoperation

New research reveals concerns about Essure, a permanent birth control device, which is already at the center of controversy. New Essure Reoperation Study Researchers found a 10-fold higher risk of...

13 Oct

Congress Urges FDA to Take Action Against Essure

October 13th, San Diego, CA- U.S. Rep. Rosa DeLauro is calling for the FDA to pull the controversial birth control implant, Essure, from the market due to recent safety concerns and...

09 Oct

What the Makers of Xarelto Don’t Want You to Know

XARELTO - FDA LETTER WARNING OF OVERPROMOTION & MISBRANDING October 9, 2015 San Diego, CA – The FDA’s letter to the maker of Xarelto basically states that the company didn’t...

Categories

Recent post

What Our Clients Say